Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Recruiting · NCT06398639 · Registry updated 2025-11-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer | Disease Attributes, Genetic Risk Score, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polygenic Risk Score, Urogenital Diseases, Urogenital Neoplasms, disease susceptibility, inherited disease susceptibility, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not applicable | 2025-11-10 | NCT06398639 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Adam S. Kibel, MD | 1 |
| National Cancer Institute (NCI) | 3015 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 1 |
| Howard University Hospital | Washington D.C. | United States | 4 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| National Cancer Institute | Bethesda | United States | 3 |
| Walter Reed National Military Medical Center | Bethesda | United States | 18 |